256 related articles for article (PubMed ID: 20726330)
1. Anti-C1q antibodies, sCD40L, TWEAK and CD4/CD8 ratio in systemic lupus erythematosus and their relations to disease activity and renal involvement.
ElGendi SS; El-Sherif WT
Egypt J Immunol; 2009; 16(1):135-48. PubMed ID: 20726330
[TBL] [Abstract][Full Text] [Related]
2. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
Smykał-Jankowiak K; Niemir ZI; Polcyn-Adamczak M
Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
[TBL] [Abstract][Full Text] [Related]
3. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
4. The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value.
Ciferská H; Horák P; Hermanová Z; Ordeltová M; Zadrazil J; Tichý T; Scudla V
Clin Rheumatol; 2007 May; 26(5):723-8. PubMed ID: 17103120
[TBL] [Abstract][Full Text] [Related]
5. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
Julkunen H; Ekblom-Kullberg S; Miettinen A
Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis.
Chi S; Yu Y; Shi J; Zhang Y; Yang J; Yang L; Liu X
Dis Markers; 2015; 2015():450351. PubMed ID: 26549923
[TBL] [Abstract][Full Text] [Related]
7. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
Emad G; Al-Barshomy SM
Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906
[TBL] [Abstract][Full Text] [Related]
8. Significance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis.
Soliman AF; Egailla SE; Abdel-Gawad ER; Mansour AI; ElKhouly TH; Mahgoub MY
Egypt J Immunol; 2016 Jan; 23(1):107-116. PubMed ID: 28502158
[TBL] [Abstract][Full Text] [Related]
9. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.
Picard C; Lega JC; Ranchin B; Cochat P; Cabrera N; Fabien N; Belot A
Pediatr Nephrol; 2017 Sep; 32(9):1537-1545. PubMed ID: 28343355
[TBL] [Abstract][Full Text] [Related]
10. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis.
Elshweikh SA; Elkhouly RM; Shaalan MM; Shorbagy SH
Egypt J Immunol; 2014; 21(2):49-59. PubMed ID: 25812352
[TBL] [Abstract][Full Text] [Related]
11. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
[TBL] [Abstract][Full Text] [Related]
12. Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China.
Zhang CQ; Ren L; Gao F; Mu FY; You YQ; Liu YH
Clin Rheumatol; 2011 Jul; 30(7):967-73. PubMed ID: 21340499
[TBL] [Abstract][Full Text] [Related]
13. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
Akhter E; Burlingame RW; Seaman AL; Magder L; Petri M
Lupus; 2011 Oct; 20(12):1267-74. PubMed ID: 21813587
[TBL] [Abstract][Full Text] [Related]
14. Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus.
Metwally IM; Eesa NN; Yacoub MH; Elsman RM
Adv Rheumatol; 2019 Mar; 59(1):10. PubMed ID: 30832710
[TBL] [Abstract][Full Text] [Related]
15. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
16. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
17. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus.
Gargiulo Mde L; Gómez G; Khoury M; Collado MV; Suárez L; Álvarez C; Sarano J
Medicina (B Aires); 2015; 75(1):23-8. PubMed ID: 25637896
[TBL] [Abstract][Full Text] [Related]
18. Value of a commercial kit for detecting anti-C1q autoantibodies and correlation with immunological and clinical activity of lupus nephritis.
de Liso F; Matinato C; Novembrino C; Radice A; Raffiotta F; Ronchi M; Croci MD; Sinico RA; Messa P; Torresani E; Moroni G
Clin Chem Lab Med; 2015 Oct; 53(11):1771-7. PubMed ID: 25870967
[TBL] [Abstract][Full Text] [Related]
19. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
Schwartz N; Rubinstein T; Burkly LC; Collins CE; Blanco I; Su L; Hojaili B; Mackay M; Aranow C; Stohl W; Rovin BH; Michaelson JS; Putterman C
Arthritis Res Ther; 2009; 11(5):R143. PubMed ID: 19785730
[TBL] [Abstract][Full Text] [Related]
20. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
Kianmehr N; Khoshmirsafa M; Shekarabi M; Falak R; Haghighi A; Masoodian M; Seif F; Omidi F; Shirani F; Dadfar N
J Immunoassay Immunochem; 2021 Jul; 42(4):406-423. PubMed ID: 33788670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]